This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.
PRIMARY OBJECTIVES: I. Biochemically verified 7-day point prevalence tobacco abstinence at 6-months follow-up. II. Use expired carbon monoxide (CO) to confirm self-reports of abstinence using a cut-off of CO ≤5 parts per million (ppm). SECONDARY OBJECTIVES: I. Biochemically-verified 7-day point prevalence tobacco abstinence at 3-months follow-up. II. Measured at 6-months follow-up, a total number of expired carbon monoxide (CO-negative samples). III. Measured at 6-months follow-up, longest duration of abstinence (i.e., total number of uninterrupted days abstinent), proportion with 50% reduction in expired CO for those who do not quit smoking. IV. Use expired CO to confirm self-reports of abstinence using a cut-off of CO ≤5 ppm. OUTLINE: Participants will be randomized to one of two groups: * Intervention group receives 6 months of pharmacist consultation, monthly delivery of nicotine replacement therapy, and telephone wellness coaching. * Control group receives pharmacist consultation and monthly delivery of nicotine replacement therapy for 3 months. Participants will be followed up at 1, 3 and 6 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
150
NRT will be administered as patch (transdermal), gum, or lozenge
Delivered via phone call
University of California, San Francisco
San Francisco, California, United States
RECRUITINGPercentage of participants who attended coaching sessions
The percentage of participants who attended at least 75% or 7 of the 14 coaching sessions will be reported.
Time frame: up to 6 months
Percentage of participants who used nicotine replacement therapy (NRT)
The percentage of participants who used at least 75% will adhere to using NRT for at least half of the treatment duration will be reported.
Time frame: up to 6 months
7-day point prevalence tobacco abstinence at month 6
Biochemically verified 7-day point prevalence tobacco abstinence at 6-months follow-up will be reported.
Time frame: 6 months
7-day point prevalence tobacco abstinence at month 3
Biochemically verified 7-day point prevalence tobacco abstinence at 3-months follow-up will be reported.
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.